FDA launches safety review of RSV infant drugs as RFK Jr. scrutinizes immunizations
The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations to face scrutiny under Health Secretary RFK, Jr.
(NBC News, 2025-12-09T17:32:58Z)